$0.93
21.18%
Nasdaq, Sep 17, 01:27 pm EDT. Market open.
ISIN
US88875G1013
Symbol
TLSA

Tiziana Life Sciences PLC Sponsored ADR Stock price

$0.77
-0.38 33.03% 1M
-0.57 42.53% 6M
-0.72 48.32% YTD
-0.90 53.89% 1Y
+0.09 13.58% 3Y
-0.90 53.89% 5Y
-0.88 53.26% 10Y
-0.88 53.26% 20Y
Nasdaq, Closing price Wed, Sep 16 2026
-0.08 9.61%
ISIN
US88875G1013
Symbol
TLSA
Industry

Is Tiziana Life Sciences PLC Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
$98.8m
Enterprise Value
$95.3m
Net debt
positive
Cash
$4.0m
Shares outstanding
120.5m
Valuation (TTM | estimate)
P/E
negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
1,976.2
Financial Health
Equity Ratio
0.5%
Return on Equity
-
ROCE
-7,286.9%
ROIC
9,605.5%
Debt/Equity
8.8
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-20.9m
EBIT
$-21.1m
Net Income
$-18.4m
Free Cash Flow
$-12.9m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-33.4%
EBIT
-33.8%
Net Income
-55.4%
Free Cash Flow
-730.3%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow
-
More
EPS
$-0.2
FCF per Share
$-0.1
Short interest
4.7%
Employees
10
Rev per Employee
-

Tiziana Life Sciences PLC Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Tiziana Life Sciences PLC Sponsored ADR forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Tiziana Life Sciences PLC Sponsored ADR forecast:

Buy
86%
Hold
14%

Financial data from Tiziana Life Sciences PLC Sponsored ADR

Dec '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense 10 10
97% 97%
-
-21 -21
33% 33%
-
- Depreciation and Amortization 0.23 0.23
92% 92%
-
EBIT (Operating Income) EBIT -21 -21
34% 34%
-
Net Profit -18 -18
55% 55%
-

In millions USD.

Don't miss a Thing! We will send you all news about Tiziana Life Sciences PLC Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tiziana Life Sciences PLC Sponsored ADR Stock News

Positive
Proactive Investors
about one hour ago
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has signed a Memorandum of Understanding with the King Abdullah International Medical Research Center (KAIMRC) and the Foundation for Neurologic Diseases to study its intranasal foralumab in combination with anti-CD20 therapy for multiple sclerosis patients. The planned trial will target relapsing-remitting multiple sclerosis (RRMS) patients who respond p...
Positive
Proactive Investors
14 days ago
Tiziana Life Sciences Ltd (NASDAQ:TLSA) was awarded a Buy rating with a $7 price target by BTIG, which pointed to the biotech's approach to modulating central nervous system inflammation as a potential leading treatment for neurodegenerative disease. The clinical-stage company is developing foralumab, an anti-CD3 antibody delivered via nasal spray, to stimulate regulatory T-cell (Treg) producti...
Neutral
Proactive Investors
24 days ago
Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it will present a poster on its Phase 2a BANYAN clinical trial of intranasal foralumab at ALS Nexus 2026 in Orlando, Florida, on Monday. The presentation, titled “Phase 2a Trial of Intranasal Foralumab – BANYAN, a Healey ALS MyMatch Trial,” is scheduled for 4:30 pm to 6:30 pm Eastern Time during the Scientific Poster Session.
More Tiziana Life Sciences PLC Sponsored ADR News

Company Profile

Tiziana Life Sciences Plc is a biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. Its lead product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom.

Head office United Kingdom
CEO Mr. Elrifi
Employees 10
Founded 1998
Website www.tizianalifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today